(Credit-Canva)
Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!
The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.
"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.
The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.
While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.
And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.
Credit: Canva
The UK Parliament has passed a “landmark bill” to ban smoking among children who were born on or after 1 January 2009.
Under the new Tobacco and Vapes Bill, people aged 17 or younger face a lifelong ban on buying cigarettes.
Both the House of Commons and Lords settled on a final draft of the legislation that aims to create a smoke-free generation.
Once it gets the royal assent, ministers will be able to regulate tobacco, vaping, and nicotine products, including their flavors as well as packaging.
“This afternoon marks the end of this bill’s journey throughout parliament. It is a landmark bill; it will create a smoke-free generation,” Health minister Baroness Merron told the House of Lords on Monday.
“It is, in fact, the biggest public health intervention in a generation, and I can assure all noble Lords it will save lives.”
Noting that the Bill “does upset a great many people in that industry”, including retailers", Lord Naseby, a Conservative former MP, called for "a proper understanding of how we educate people not to take up smoking”.
It was first proposed by former UK Prime Minister Rishi Sunak On 4 October 2023 at the Conservative Party conference in Manchester. He shared plans to phase out cigarette smoking in the UK by raising the minimum age to purchase cigarettes from 18 each year, every year, until eventually no person can legally buy cigarettes. A similar proposal was made by the Labour Party earlier that year.
Plans for the Tobacco and Vapes Bill, legislation implementing such a ban, were announced in the King's Speech during the 2023 State Opening of Parliament.
The bill passed its first reading on 20 March 2024 and its second reading on 16 April 2024.
Also read: Banning Tobacco Can Save 1.2 million Lives By 2095
On 24 October 2024, the new government announced a ban on the sale of single use vapes, effective from June 2025, in an effort to address environmental concerns and the rising prevalence of vaping among children.
Under the new Bill,
Also read: UK Bans Disposable Vape: Will This Really Stop Young People And Reduce Waste?
Smoking is the most common risk factor and the single biggest cause of preventable death for a host of diseases, ranging from respiratory diseases to tuberculosis to cancer.
Smoking damages the human body and causes
There are safer alternatives to aluminium foil. (Photo credit: iStock)
People use aluminium foil as a common cooking tool and food storage solution, which studies show to be safe for most people when used occasionally. The proper method of use determines whether it functions as the best solution for storing food over extended periods. People can store dry, uncooked items in foil because it creates fewer safety risks than keeping reactive foods for extended periods. Ms Aditi Prasad Apte, Senior Clinical Nutritionist at Aster RV Hospital, Bangalore, in an interview with Health and Me, spoke about the dangers of storing food in aluminium foil. The expert also shared alternatives that are safer and can be helpful.
People who eat food processed with aluminium may ingest small amounts of aluminium through their meals. The likelihood of this occurrence increases when particular conditions exist, which include using food that contains heat, acid, salt, or strong spices. These include tomatoes, citrus, vinegar, and strongly flavoured foods. Heat increases the transfer, which means that wrapping hot food directly in foil produces higher transfer rates than covering leftovers for short periods. One should understand that storing hot food in foil can create food safety issues because of aluminium contamination.
The use of foil creates an incomplete airtight seal, which results in insufficient cooling and creates unsafe storage conditions when food remains at dangerous temperatures for extended periods. The health risks connected to long-term excessive aluminium exposure have remained a topic of scientific discussion for many years. The bodies of healthy people process and remove aluminium consumed through food mainly via the kidneys.
People who have kidney problems must handle aluminium exposure with special caution. Research has studied the links between high aluminium exposure and neurological and bone problems, but has found no proof that using foil for daily activities leads to these medical issues. The larger issue requires people to take steps to reduce their exposure to unnecessary risks whenever possible.
Safer alternatives for routine storage include glass containers, stainless steel containers, ceramic storage, and food-grade silicone options. These products provide specific benefits for storing hot leftovers, acidic foods, and items that need to be kept in refrigerators for extended periods. Parchment paper may also be a better barrier than foil in some cooking situations.
There are also several myths worth clarifying. Some people believe that aluminium foil contains harmful substances that make it unsafe to use. Normal, occasional use is not the same as dangerous exposure. Another myth is that foil always reacts with food; in reality, reaction risk depends heavily on the type of food, temperature, and duration of contact.
The fact is that foil works better for wrapping food and providing temporary coverage than it does as a standard storage method. The best approach requires people to use aluminium foil appropriately in cooking situations. People should not store acidic or hot food in foil for extended periods, and they should not consume food that has come into contact with damaged foil. The safest approach for regular home use is to use foil only when necessary, while understanding which materials work better in specific situations.
Credit: iStock
With the launch of generic versions of Ozempic, Wegovy, and Mounjaro, the demand for these weight loss and diabetes medications is skyrocketing in India. Amid the rising demand, there is also a surge of counterfeit jabs—often sold through unregulated online vendors—that can endanger lives.
According to a Reuters report, Indian drug regulators have seized more than 260 suspected counterfeit pens of Eli Lilly's popular obesity and diabetes drug Mounjaro, worth Rs 7 million, from the northern state of Haryana.
The suspected fake pens were recovered from a vehicle on the outskirts of New Delhi, and were kept under improper temperature conditions and appeared in different font sizes compared with the original product, which raised suspicion of being counterfeit.
The Haryana Food and Drug Control Administration has also arrested two people accused of making and selling the drugs. The primary accused did not have a pharmaceutical license and made the products at a private property, Drug Control Officer Amandeep Chauhan told Reuters. They had ordered peptides used in the drugs and other raw materials from vendors on the Chinese e-commerce platform Alibaba.
The arrested duo also sold the pens on the online marketplace IndiaMART at a 27 per cent discount to the original drug's price, Chauhan said.
While samples have been sent to government-run laboratories for confirmation, Eli Lilly and Company (India) spokesperson issued a statement welcoming the action against illicit medicines.
Noting that it "takes patient safety extremely seriously", the company stated that it's "actively supporting the investigation and will continue to work with regulatory and law enforcement authorities worldwide to protect patients from the risks of counterfeit products".
Also read: Lehengas, Diets & Now Mounjaro: The New Must-Have For Indian Brides?
The short answer: extremely. The risks go far beyond inefficacy. Some fake jabs contain:
Read More: Can Weight Loss Jabs Surge Divorce Rates? What Experts Are Saying
Counterfeit products may have
These are indicators that the medicine has not been produced by the original manufacturer or is being illegally sold in the wrong market.
Further, counterfeit drugs are often sold on social media platforms like Instagram, TikTok, or salon backrooms.
Also read: India To Strictly Inspect GLP-1 Drugs To Curb Misuse: Govt Flags Risks Amid Weight-loss Hype
Another major lure of counterfeit Ozempic/Mounjaro is the price tag—black-market versions are often heavily discounted. But remember: this comes at the cost of your health, safety, and potentially, your life.
If you’re unsure about a product, consult your pharmacist or primary care provider. Always ensure that any medication you take has been prescribed by a qualified healthcare provider and obtained from a licensed source.
© 2024 Bennett, Coleman & Company Limited